A detailed history of Greenland Capital Management LP transactions in Axonics, Inc. stock. As of the latest transaction made, Greenland Capital Management LP holds 16,297 shares of AXNX stock, worth $1.15 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
16,297
Holding current value
$1.15 Million
% of portfolio
0.16%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$66.47 - $69.65 $1.08 Million - $1.14 Million
16,297 New
16,297 $1.1 Billion

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.46B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Greenland Capital Management LP Portfolio

Follow Greenland Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenland Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Greenland Capital Management LP with notifications on news.